{"id":"W2791438625","doi":"10.1007/s11864-018-0532-2","title":"When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nilotinib; Chronic myelogenous leukemia; Dasatinib; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Clinical trial; Clinical endpoint; Intensive care medicine; Imatinib; Leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001268666,0.0004215637,0.000933896,0.001022272,0.0002806401,0.001032821,0.001495458,0.002830734,0.005893555],"category_scores_gemma":[0.003518346,0.0001794729,0.0006808839,0.0008629054,0.0005685287,0.002558755,0.0005461117,0.00329429,0.003906512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005718387,"about_ca_system_score_gemma":0.001477832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000807412,"about_ca_topic_score_gemma":0.001727407,"domain_scores_codex":[0.9992868,0.0001635876,0.0001493452,0.0000751273,0.0002849791,0.00004015001],"domain_scores_gemma":[0.9984034,0.0006756629,0.000272519,0.00002967632,0.0005411111,0.00007769738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007707022,0.00003982854,0.0001720776,0.01540309,0.0000841241,0.0002752299,0.00007307002,0.0001314882,0.0005898699,0.003874627,0.3685492,0.6107303],"study_design_scores_gemma":[0.00003183573,0.00003683854,0.0003842128,0.007793172,0.00008124518,0.0009406072,0.00005903434,0.00005407741,0.0001575608,0.002493253,0.9879541,0.0000141156],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002138497,0.951517,0.0003989805,0.03748584,0.006034623,0.00003006389,0.0001405909,0.00002597633,0.00415302],"genre_scores_gemma":[0.001661524,0.9738947,0.0006870158,0.01717078,0.003872767,0.00003749781,0.0001987643,0.000009127762,0.002467702],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005893555,"threshold_uncertainty_score":0.01971591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071103467826513,"score_gpt":0.4213271519235706,"score_spread":0.3142168051409193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}